Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Background Kidney transplantation is the optimal treatment modality for patients with end-stage kidney disease. We aimed to identify predictors for post-transplantation complications. Methods A prospective cohort study with 1-year follow-up on 40 recipients (with their donors) were recruited and followed up for 1 year after transplantation. The patients were classified into two groups according to development of complications or not. Results It was found that renal recipient had significantly lower mean age compared to donors (30.55 ± 10.24 vs. 41.28 ± 9.83 (years); p < 0.001). The reported complications were hypertension (42.5%), proteinuria (17.5%), surgical difficulty (17.5%), chronic rejection (12.5%), DM (7.5%), and other less common complications. Death occurred in six recipients. Significant predictors for complications were history of DM (OR = 3.429; 95% CI = 1.148–5.058; p = 0.044), BUN (OR = 2.501; 95% CI = 1.094–4.007; p = 0.038), creatinine (OR = 1.90; 95% CI = 1.025–2.806; p = 0.015), older age (OR = 1.854; 95% CI = 1.090–3.195; p = 0.033), pre-transplantation leucocytic count (OR = 1.775; 95% CI = 1.057–3.901; p = 0.039), and LDL (OR = 1.051; 95% CI = 1.009–2.441; p = 0.047). Elevated PTH in pre-transplantation showed significantly slight protective effect against development of complications (OR = 0.915; 95% CI = 0.624–0.957; p = 0.031). Conclusion Complications are common after kidney transplant in our population and are associated with history of DM, pre-transplantation BUN, creatinine, and older age, while elevated pretransplant PTH showed slightly protective effect.
Background Kidney transplantation is the optimal treatment modality for patients with end-stage kidney disease. We aimed to identify predictors for post-transplantation complications. Methods A prospective cohort study with 1-year follow-up on 40 recipients (with their donors) were recruited and followed up for 1 year after transplantation. The patients were classified into two groups according to development of complications or not. Results It was found that renal recipient had significantly lower mean age compared to donors (30.55 ± 10.24 vs. 41.28 ± 9.83 (years); p < 0.001). The reported complications were hypertension (42.5%), proteinuria (17.5%), surgical difficulty (17.5%), chronic rejection (12.5%), DM (7.5%), and other less common complications. Death occurred in six recipients. Significant predictors for complications were history of DM (OR = 3.429; 95% CI = 1.148–5.058; p = 0.044), BUN (OR = 2.501; 95% CI = 1.094–4.007; p = 0.038), creatinine (OR = 1.90; 95% CI = 1.025–2.806; p = 0.015), older age (OR = 1.854; 95% CI = 1.090–3.195; p = 0.033), pre-transplantation leucocytic count (OR = 1.775; 95% CI = 1.057–3.901; p = 0.039), and LDL (OR = 1.051; 95% CI = 1.009–2.441; p = 0.047). Elevated PTH in pre-transplantation showed significantly slight protective effect against development of complications (OR = 0.915; 95% CI = 0.624–0.957; p = 0.031). Conclusion Complications are common after kidney transplant in our population and are associated with history of DM, pre-transplantation BUN, creatinine, and older age, while elevated pretransplant PTH showed slightly protective effect.
Objectives: After renal transplantation, a remarkable improvement of impaired patient’s kidney function is often observed. Preserving improved kidney function ensures long-term renal allograft survival. However, there are different risk factors; the acute rejection is the major risk factor. Therefore, the aim of the present study was to examine renal function within the first six months as independent variables in predicting long-term survival and incidence of acute rejection. Methods: Fifty-three patients who underwent kidney transplantation in 2016 and 2017 in King Abdulaziz Medical City- National Guard were evaluated consecutively1 and 2-month pre-transplant up to six months’ post-transplant. Time course of changes in kidney functions; measurements of serum creatinine (Scr), blood urea nitrogen(BUN), albumin, calcium, sodium and potassium were recorded. Estimated glomerular filtration rate (eGFR) and anion gap (AGAP) were also reported. In addition, age, anthropometric factors and causes of ESRD were analyzed. Results: Lower level of calcium was observed in 40% of patient’s two-month pre-transplantation and 69% of patients one month before. Normalization of calcium was achieved in all patients starting from second month post-transplantation. All patients presented elevated serum potassium level in pre-transplant months, however, renal transplant normalize potassium level starting from first month. A remarkable higher level of serum BUN was observed in all pre-transplant patients followed by dramatically decreased after renal transplant for first four months and remain in normal level starting from month 5. Likewise, serum creatinine was highly elevated in all pre-transplant patients. A profound reduction in serum creatinine started from month 1 post-transplant and normalizes at month 4. Moreover, both eGFR and AGAP were kept in normal level immediately after renal transplantation. All patients with early acute rejection during mean follow-up period have a remarkable elevated level of serum creatinine and profound decrease in eGFR starting from first month. While a significant higher level of serum BUN observed in fifth month only and serum albumin in third month. Conclusion: Significant elevation of serum creatinine and reduction in eGFR starting from first month were associated with post-transplanted patients with early acute rejection. The clinical use of eGFR and serum creatinine may aid in predicting incidence of early acute rejection.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.